Clinical Trial Update: A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers [Phase 1]

View source ↗

Summary

Clinical trial update indicating Janssen's investigational asset JNJ-89402638 is in Phase 1 testing for metastatic colorectal and gastric cancers and is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Gastric Cancer

Drugs mentioned

• JNJ-89402638

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Colorectal Neoplasms, Gastrointestinal Neoplasms | Phase 1 | Status: RECRUITING